Checkmate Pharmaceuticals Inc
NASDAQ:CMPI
Checkmate Pharmaceuticals Inc
NASDAQ:CMPI
Price:
10.5 USD
Market Closed
Updated:
May 22, 2024
Balance Sheet
Balance Sheet Decomposition
Checkmate Pharmaceuticals Inc
Checkmate Pharmaceuticals Inc
| Current Assets | 62.1m |
| Cash & Short-Term Investments | 60m |
| Other Current Assets | 2.1m |
| Non-Current Assets | 4.8m |
| PP&E | 730k |
| Other Non-Current Assets | 4.1m |
| Current Liabilities | 11.9m |
| Accounts Payable | 3.6m |
| Accrued Liabilities | 8.3m |
Balance Sheet
Checkmate Pharmaceuticals Inc
Checkmate Pharmaceuticals Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
12
|
4
|
43
|
51
|
|
| Cash Equivalents |
12
|
4
|
43
|
51
|
|
| Short-Term Investments |
0
|
0
|
52
|
20
|
|
| Other Current Assets |
0
|
1
|
7
|
3
|
|
| Total Current Assets |
13
|
5
|
102
|
74
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
31
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
4
|
|
| Total Assets |
13
N/A
|
5
-59%
|
133
+2 510%
|
79
-41%
|
|
| Liabilities | |||||
| Accounts Payable |
2
|
2
|
2
|
3
|
|
| Accrued Liabilities |
2
|
3
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
6
|
8
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
6
+70%
|
8
+41%
|
9
+19%
|
|
| Equity | |||||
| Common Stock |
72
|
97
|
0
|
0
|
|
| Retained Earnings |
63
|
97
|
140
|
201
|
|
| Additional Paid In Capital |
0
|
0
|
265
|
271
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
1
N/A
|
125
N/A
|
69
-45%
|
|
| Total Liabilities & Equity |
13
N/A
|
5
-59%
|
133
+2 510%
|
79
-41%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
21
|
21
|
22
|
22
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
